AcquisitionOther
Fulgent Genetics, Inc. acquired Bako Diagnostics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Fulgent Genetics, Inc. -> Bako Diagnostics · $55.5 million
Fulgent Genetics continues to build upon its laboratory services platform both organically and inorganically through multiple vectors, including expanding its test menu through R&D, partnerships, and acquisitions; increasing accessibility by adding covered liv
Open source record (SEC) ↗